TVM Capital Life Science Overview

TVM Capital Life Science is a leading international venture capital firm focused on investing in life science innovations. With approximately €900 million under management, the firm has a transatlantic investment team and offices in Munich, Germany, and Montreal, Canada. TVM's portfolio emphasizes therapeutics and medical technologies from North America and the EU that represent differentiated first-in-class or best-in-class assets with the potential to transform standard of care. The firm employs a unique two-pronged strategy: financing innovative early-stage therapeutics through a single asset company approach (Project-Focused Company, PFC) that leverages its strategic relationship with global pharmaceutical firm Eli Lilly and Company, and investing in differentiated commercial-stage medical technologies and late clinical-stage therapeutics.

Is TVM Capital Life Science the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with TVM Capital Life Science, along with a list of other relevant VCs, is available on Hopohopo.io.